Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

PHI-101 MeSH Supplementary Concept Data 2025


MeSH Supplementary
PHI-101
Unique ID
C000723077
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000723077
Entry Term(s)
3-(carbamoylamino)-5-(2-(3-fluorophenyl)ethynyl)-N-((3S)-piperidin-3-yl)thiophene-2-carboxamide
Pharm Action
Immune Checkpoint Inhibitors
Registry Numbers
0
Heading Mapped to
*Piperidines
*Sulfur Compounds
Frequency
0
Note
an orally available, selective checkpoint kinase 2 (Chk2) inhibitor
Source
BMC Cancer . 2022 Jan 3;22(1):28.
Date of Entry
2022/08/09
Revision Date
2022/08/09
PHI-101 Preferred
page delivered in 0.004s